In Vitro Efficacy of Chlorhexidine and a riboflavin/UVA Combination on Fungal Agents of Keratitis

References

• Thomas PA, Kaliamurthy J. Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect. 2013;19(3):210–20. doi:10.1111/1469-0691.12126.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Murat D, Kojima T, Shimazaki J, Tsubota K. The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis. Br J Ophthalmol. 2011;95(10):1406–09. doi:10.1136/bjo.2010.191734.
   PubMed Web of Science ®Google Scholar
• Kredics L, Narendran V, Shobana CS, Vaglögyi C, Manikandan P. Filamentous fungal infections of the cornea: a global overview of epidemiology and drug sensitivity. Mycoses. 2015;58(4):243–60. doi:10.1111/myc.12306.
   PubMed Web of Science ®Google Scholar
• Garg P, Roy A, Roy S. Update on fungal keratitis. Curr Opin Ophthalmol. 2016;27(4):333–39. doi:10.1097/ICU.0000000000000272.
   PubMed Web of Science ®Google Scholar
• Ng JK, Fraunfelder FW, Winthrop KL. Review and update on the epidemiology, clinical presentation, diagnosis, and treatment of fungal keratitis. Curr Fungal Infect Rep. 2013;7(4):293–300. doi:10.1007/s12281-013-0163-9.
   Google Scholar
• Lalitha P, Sun CQ, Prajna NV. In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial. Am J Ophthalmol. 2014;157(2):318–26. doi:10.1016/j.ajo.2013.10.004.
   PubMed Web of Science ®Google Scholar
• Rakeman JL, Bui U, LaFe K, Chen Y-C, Honeycutt RJ, Cookson BT. Multilocus DNA sequence comparisons rapidly identify pathogenic molds. J Clin Microbiol. 2005;43(7):3324–33. doi:10.1128/JCM.43.7.3324-3333.2005.
   PubMed Web of Science ®Google Scholar
• Kalaiselvi G, Narayana S, Krishnan T, Sengupta S. Intrastromal voriconazole for deep recalcitrant fungal keratitis: a case series. Br J Ophthalmol. 2015;99(2):195–98. doi:10.1136/bjophthalmol-2014-305412.
   PubMed Web of Science ®Google Scholar
• Guber I, Bergin C, Majo F. Repeated intrastromal injections of voriconazole in combination with corneal debridement for recalcitrant fungal keratitis - a case series. Klin Monbl Augenheilkd. 2016;233(4):369–72. doi:10.1055/s-0041-111814.
   PubMed Web of Science ®Google Scholar
• McDonald EM, Ram FS, Patel DV, McGheei CN. Effectiveness of topical antifungal drugs in the management of fungal keratitis: A systematic review and meta-analysis of randomized controlled trials. Asia Pac J Ophthalmol (Phila). 2014;3(1):41–47. doi:10.1097/APO.0b013e3182a618dd.
   PubMedGoogle Scholar
• Wollensak G, Spörl E, Seiler T. Treatment of keratoconus by collagen cross linking. Ophthalmologe. 2003;100(1):44–49. doi:10.1007/s00347-002-0700-3.
   PubMed Web of Science ®Google Scholar
• Martins SA, Combs JC, Noguera G, Camacho W, Wittmann P, Walther R. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci. 2008;49(8):3402–08. doi:10.1167/iovs.07-0624.
   PubMed Web of Science ®Google Scholar
• Hafezi F, Randleman JB. PACK-CXL: defining CXL for infectious keratitis. J Refract Surg. 2014;30(7):438–39. doi:10.3928/1081597X-20140609-01.
   PubMed Web of Science ®Google Scholar
• Alio JL, Abbouda A, Valle DD, Del Castillo JM, Fernandez JA. Corneal cross-linking and infectious keratitis: a systematic review with a meta-analysis of reported cases. J Ophthalmic Inflamm Inf. 2013;3(1):47. doi:10.1186/1869-5760-3-47.
   PubMedGoogle Scholar
• Uddaraju M, Mascarenhas J, Das MR, Radhakrishnan N, Keenan JD, Prajna L, Prajna VN. Corneal cross-linking as an adjuvant therapy in the management of recalcitrant deep stromal fungal keratitis: a randomized trial. Am J Ophthalmol. 2015;160(1):131–34. doi:10.1016/j.ajo.2015.03.024.
   PubMed Web of Science ®Google Scholar
• Tabibian D, Mazzotta C, Hafezi F. PACK-CXL: corneal cross-linking in infectious keratitis. Eye Vis. 2016;3:11. doi:10.1186/s40662-016-0042-x.
   PubMedGoogle Scholar
• Samson RA, Visagie CM, Houbraken J, Hong SB, Hubka V, Klaassen CH, Perrone G, Seifert KA, Susca A, Tanney JB, et al. Phylogeny, identification and nomenclature of the genus Aspergillus. Stud Mycol. 2014;78:141–73. doi:10.1016/j.simyco.2014.07.004.
   PubMed Web of Science ®Google Scholar
• Homa M, Shobana CS, Singh YR, Manikandan P, Selvam KP, Kredics L, Narendan V, Vagvolgyi C, Galgoczy L. Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex. Mycoses. 2013;56(5):501–11. doi:10.1111/myc.12062.
   PubMed Web of Science ®Google Scholar
• Bilgihan K, Kalkanci A, Ozdemir HB, Yazar R, Karakurt F, Yuksel E, Otag F, Karabicak N, Arikan-Akdagli S. Evaluation of antifungal efficacy of 0.1% and 0.25% riboflavin with UVA: A comparative in vitro study. Curr Eye Res. 2016;41(8):1050–56. doi:10.3109/02713683.2015.1088956.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard. 2nd ed. Wayne (PA, USA): CLSI; 2008.
   Google Scholar
• Ortillés Á, Belloc J, Rubio E, Fernandez MT, Benito M, Cristobal JA, Calvo B, Goni P. In vitro development of an effective treatment for Acanthamoeba keratitis. Int J Antimicrob Agents. 2017;50(3):325–33. doi:10.1016/j.ijantimicag.2017.03.033.
   PubMed Web of Science ®Google Scholar
• Sunada A, Kimura K, Nishi I, Toyokawa M, Ueada A, Sakata T, Suzuki T, Inoue Y, Ohashi Y, Asari S, et al. In vitro evaluations of topical agents to treat Acanthamoeba keratitis. Ophthalmology. 2014;121(10):2059–65. doi:10.1016/j.ophtha.2014.04.013.
   PubMed Web of Science ®Google Scholar
• Oliveira Dos Santos C, Kolwijck E, van der Lee HA, Tehupeiory-Kooreman MC, Al-Hatmi AMS, Matayan E, Burton MJ, Eggink CA, Verweij PE. vitro activity of chlorhexidine compared with seven antifungal agents against 98 Fusarium isolates recovered from fungal keratitis patients. Antimicrob Agents Chemother. 2019. doi:10.1128/AAC.02669-18.
   PubMed Web of Science ®Google Scholar
• Vazirani J, Vaddavalli PK. Cross-linking for microbial keratitis. Indian J Ophthalmol. 2013;61(8):441–44. doi:10.4103/0301-4738.116068.
   PubMed Web of Science ®Google Scholar
• Tabibian D, Richoz O, Riat A, Schrenzel J, Hafezi F. Accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking as a first-line and sole treatment in early fungal keratitis. J Refract Surg. 2014;30(12):855–57. doi:10.3928/1081597X-20141113-06.
   PubMed Web of Science ®Google Scholar
• Hao ZQ, Song JX, Pan SY, Zhang L, Cheng Y, Liu XN, Wu J, Xiao XH, Gao W, Zhu HF. Corneal collagen cross-linking and liposomal amphotericin B combination therapy for fungal keratitis in rabbits. Int J Ophthalmol. 2016;9:1549–54.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhang H, Yue J, Liu S, Li Z, Wang L. Antimicrobial efficacy of corneal cross-linking in vitro and in vivo for Fusarium solani: a potential new treatment for fungal keratitis. BMC Ophthalmol. 2018;18(1):65. doi:10.1186/s12886-018-0727-0.
   PubMed Web of Science ®Google Scholar
• Özdemir HB, Kalkancı A, Bilgihan K, Göçün PU, Öğüt B, Karakurt F, Erdoğan M. Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis. Acta Ophthalmol. 2019;97(1):e91–e96. doi:10.1111/aos.13829.
   PubMed Web of Science ®Google Scholar
• Vajpayee RB, Shafi SN, Maharana PK, Sharma N, Jhanji V. Evaluation of corneal collagen cross-linking as an additional therapy in mycotic keratitis. Clin Exp Ophthalmol. 2015;43(2):103–07. doi:10.1111/ceo.12399.
   PubMed Web of Science ®Google Scholar
• Erdem E, Harbiyeli II, Boral H, Ilkit M, Yagmur M, Ersoz R. Corneal collagen cross-linking for the management of mycotic keratitis. Mycopathologia. 2018;183(3):521–27. doi:10.1007/s11046-018-0247-8.
   PubMed Web of Science ®Google Scholar
• Chan TC, Agarwal T, Vajpayee RB, Jhanji V. Cross-linking for microbial keratitis. Curr Opin Ophthalmol. 2016;27(4):348. doi:10.1097/ICU.0000000000000271.
   PubMed Web of Science ®Google Scholar
• Tsugita A, Okada Y, Uehara K. Photosensitized inactivation of ribonucleic acids in the presence of riboflavin. Biochim Biophys Acta. 1965;103(2):360–63. doi:10.1016/0005-2787(65)90182-6.
   PubMed Web of Science ®Google Scholar
• Wang T, Peng Y, Shen N, Yu Y, Yao M, Zhu J. Photochemical activation increases the porcine corneal stiffness and resistance to collagenase digestion. Exp Eye Res. 2014;123:97–104. doi:10.1016/j.exer.2014.04.008.
   PubMed Web of Science ®Google Scholar
• Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UVA-riboflavin cross-linking of the cornea. Cornea. 2007;26(4):385–89. doi:10.1097/ICO.0b013e3180334f78.
   PubMed Web of Science ®Google Scholar
• Geffen N, Norman G, Kheradiya NS, Assia EI. Chlorhexidine gluconate 0.02% as adjunct to primary treatment for corneal bacterial ulcers. Isr Med Assoc J. 2009;11:664–68.
   PubMed Web of Science ®Google Scholar
• Martín-Navarro CM, Lorenzo-Morales J, Cabrera-Serra MG, Rancel F, Coronado-Alvarez NM, Pinero JE, Valladares B. The potential pathogenicity of chlorhexidine-sensitive Acanthamoeba strains isolated from contact lens cases from asymptomatic individuals in Tenerife, Canary Islands, Spain. J Med Microbiol. 2008;57(Pt 11):1399–404. doi:10.1099/jmm.0.2008/003459-0.
   PubMed Web of Science ®Google Scholar
• Rahman MR, Johnson GJ, Husain R, Howlader SA, Minassian DC. Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. Br J Ophthalmol. 1998;82(8):919–25. doi:10.1136/bjo.82.8.919.
   PubMed Web of Science ®Google Scholar
• Boral H, van Diepeningen A, Erdem E, Yagmur M, de Hoog GS, Ilkit M, Meis JF, Al-Hatmi AMS. Mycotic keratitis caused by Fusarium solani sensu stricto (FSSC5): A case series. Mycopathologia. 2018;183(5):835–40. doi:10.1007/s11046-018-0280-7.
   PubMed Web of Science ®Google Scholar
• Taj-Aldeen SJ, Salah H, Al-Hatmi AM, Hamed M, Theelen B, van Diepeningen AD, Boekhout T, Lass-Flörl C. In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method. Diagn Microbiol Infect Dis. 2016;85(4):438–43. doi:10.1016/j.diagmicrobio.2016.05.006.
   PubMed Web of Science ®Google Scholar